36th Annual Fall Foliage Cancer Conference
In-Person Event
Oct 24 - 25, 2025
Asheville, North Carolina, USA
10 AMA PRA Category 1 Credits™ ...
OVERVIEW
36th Annual Fall Foliage Cancer Conference is organized by Continuing Cancer Education (CCE), Inc. and will be held from Oct 24 - 25, 2025 at The Omni Grove Park Inn, Asheville, North Carolina, United States of America.
“Important: Prices increase by $30 after September 1. Don’t wait!”
Learner Objectives:
At the conclusion of this activity, participants should be better able to:
- Discuss the advances in the management of muscle-invasive bladder cancer.
- Describe emerging developments in immunologic and targeted therapies for metastatic bladder cancer.
- Identify recent advancements in trimodality therapy for bladder cancer.
- Describe contemporary surgical management approaches for renal cell cancer.
- Define systemic therapy for renal cell carcinoma immunotherapy versus immunotherapy with a tyrosine kinase inhibitor.
- Evaluate the role of next generation imaging in the treatment of advanced prostate cancer.
- Discuss systemic advancements in prostate cancer.
- Review surgical options in the management of prostate cancer.
- Explain the treatments for high risk locally advanced oligometastatic disease in prostate cancer.
- Evaluate the use of proton versus photon therapy in prostate cancer.
The Presentations Include:
- Metastatic Bladder Cancer: Targeted Therapies and Immunotherapy; Trimodality Therapy in Bladder Cancer and Management of Muscle-Invasive Bladder Cancer
- Renal Cell Carcinoma: Contemporary Surgical Management and Systemic Therapy: Immunotherapy vs Immunotherapy & TKIs
- Prostate Cancer: Diagnosis, Risk Management & Surgical Management; Next Generation Imaging in Advanced Prostate Cancer; Systemic Treatment; High-Risk Locally Advanced Oligometastatic Disease and Proton vs Photon Therapy
AGENDA:
| Friday, October 24, 2025 | |
| 8:00 – 10:00am | Registration/Exhibit Space Open |
| 10:00 -10:45am | Contemporary Surgical Management of Renal Cell Carcinoma Steven Campbell, MD, PhD |
| 10:45 – 11:00 am | Questions & Answers |
| 11:00 – 11:45 am | Systemic Therapy for Renal Cell Carcinoma: Immunotherapy vs Immunotherapy & TKIs Kathryn Beckermann, MD, PhD |
| 12:00 – 1:00 pm | Lunch (sponsored with speaker non-CME) |
| 1:00 – 1:45 pm | Management of Muscle-Invasive Bladder Cancer Matthew Milowsky, MD, FASCO |
| 1:45 – 2:00 pm | Questions & Answers |
| 2:00 – 2:45 pm | Update on Diagnosis, Risk Assessment and Surgical Management of Localized Prostate Cancer 2025 Judd Moul, MD |
| 2:45 – 3:00 pm | Questions & Answers |
| 3:00 – 3:45 pm | Role of Next-Generation Imaging in Treatment for Advanced Prostate Cancer Anton Becker, MD, PhD |
| 3:45 – 4:00 pm | Questions & Answers |
| Saturday, October 25, 2025 | |
| 8:00 – 9:00 am | Breakfast (sponsored with speaker non-CME) |
| 9:00 – 9:45 am | High Risk Locally Advanced Oligometastatic Disease Jason Efstathiou, MD, DPhil |
| 9:45 – 10:00 am | Questions & Answers |
| 10:00 – 10:45 am | Metastatic Bladder Cancer: Immunologic & Targeted Approaches Gopa Iyer, MD |
| 10:45 – 11:00 am | Questions & Answers |
| 11:00 – 11:45 am | Trimodality Therapy in Bladder Cancer Alex Zlotta, MD, PHD, FRCSC |
| 11:45 – 12:00 pm | Questions & Answers |
| 12:00 – 1:00 pm | Lunch (sponsored with speaker non-CME) |
| 1:00 – 1:45 pm | Theranostics in Prostate Cancer Sanoj Punnen, MD, MAS |
| 1:45 – 2:00 pm | Questions & Answers |
| 2:00 – 2:45 pm | Proton vs Photon Therapy in Prostate Cancer Jason Efstathiou, MD, DPhil |
| 2:45 – 3:00 pm | Questions & Answers |
KEY DATES
24 Oct, 2025
Event Start Date
25 Oct, 2025
Event End Date
ACCREDITATION & CREDITS
Accreditation Statement:
This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Arizona Medical Association (ArMA) through the joint providership of MORE Foundation and Continuing Cancer Education, Inc. MORE Foundation is accredited by ArMA to provide continuing medical education for physicians.
Credit Statement:
MORE Foundation designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ASRT:
The ASRT has approved this activity for Category A credits, Friday 6.0 hours and Saturday 6.0 hours. No partial credit is awarded. You must attend all day.
Credits:
Credit Statements
- MORE Foundation designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits.
- The ASRT has approved this activity for Category A Credits, Friday 6.0 and Saturday 6.0. No partial credit is awarded. You must attend all day.
TARGET AUDIENCE
PhysicianOncologistsResidentsAllied Health ProfessionalsFellowsRenal PractitionersRadiation OncologistsMedical OncologistsOncological Nursing StaffSPECIALITIES
Oncology NursingOncologyRadiation OncologyCONFERENCE SUMMARY
The 36th Annual Fall Foliage Cancer Conference is set to take place in 2025, bringing together leading experts in oncology. This premier event will focus on the latest advancements in cancer research, treatment options, and patient care strategies. Attendees can expect insightful presentations, interactive sessions, and networking opportunities with professionals from across the globe. The conference aims to enhance knowledge and foster collaboration in the fight against cancer. Don't miss this chance to stay updated on critical developments in oncology and connect with peers in the field.
SUGGESTED HOTELS
CONFERENCE VENUE
The Omni Grove Park InnRELATED CONFERENCES & LIVE WEBINARS
Quick Links